All articles posted in Business & Economy

Takeda CEO talks globalization, innovation in pharmaceutical industry

Christophe Weber, pres­i­dent and CEO of Takeda Phar­ma­ceu­tical Com­pany Ltd., shared his global vision, mul­ti­cul­tural per­spec­tive, and long-​​term approach to run­ning the 235-​​year-​​old Japanese com­pany on Tuesday at Northeastern’s CEO Break­fast Forum speaker series.

Would Abraham Lincoln have voted for Trump or Clinton?

To ease the ten­sion of Elec­tion Day, we asked seven fac­ulty mem­bers to par­tic­i­pate a quirky thought exper­i­ment that chal­lenged each of them to con­sider how one well known but long dead person in their respec­tive fields would have voted in the 2016 pres­i­den­tial elec­tion. The responses were insightful, sobering, and occa­sion­ally hilarious.

Pro-​​GMO: Nobel laureate makes the case for genetic modification

Thursday night at North­eastern, Nobel lau­reate and Dis­tin­guished Uni­ver­sity Pro­fessor Sir Richard Roberts argued that despite what you may have heard, GMOs are safe and have the poten­tial to save lives in devel­oping coun­tries. Here are five key points from his talk.

Northeastern launches loan program for women and minority entrepreneurs

North­eastern Uni­ver­sity announced on Tuesday that it will launch the region’s first university-​​supported loan pro­gram for women– and minority-​​owned busi­nesses. The ini­tia­tive, called the Impact Lending pro­gram, will enable local small-​​business owners to secure loans, at below-​​market interest rates, to acquire cru­cial resources to expand their businesses.

President Aoun, HUBweek panel discuss the workforce of the future

We need to build what I call a robot-​​proof edu­ca­tion,” Pres­i­dent Aoun said on Wednesday. The com­ments came during a HUB­week panel dis­cus­sion about the role higher edu­ca­tion should play in building the 21st-​​century workforce.

Looking to turn an idea into a business? Husky Startup Challenge offers just that

Turning an idea into a busi­ness takes a lot of work and strategic planning—both of which the Husky Startup Chal­lenge pro­gram can help foster. The first step, though, is signing up, and appli­ca­tions close at mid­night tonight.

3Qs: What the Lochte saga can teach us about branding

After get­ting dropped by all his major spon­sors, Olympic swimmer Ryan Lochte signed a new endorse­ment deal with a little-​​known cough drop com­pany. It’s a poten­tially low-​​risk, high-​​reward move for both the ath­lete and the brand, says pro­fessor Bruce Clark.

EpiPen’s pricing debacle and its impact on patients, insurers

A firestorm erupted this week in response to the phar­ma­ceu­tical com­pany Mylan’s sharp increase in the price of its EpiPen, a life-​​saving treat­ment for severe allergic reac­tions. The com­pany quickly back­tracked, announcing a rebate plan. Here, three North­eastern fac­ulty members—pharmacist Tayla Rose, health­care finance expert Steven Pizer, and health policy researcher Gary Young—explain the clin­ical, eco­nomic, and policy impli­ca­tions of the controversy.

3Qs: The cat-​​and-​​mouse game of blocking digital ads

If you were using Face­book on a desktop last week, you may have noticed that your ad-​​blocking soft­ware was being blocked. That was a move by Face­book. We asked two North­eastern pro­fes­sors to explain how new strate­gies and tech­nolo­gies are changing the dig­ital land­scape for users, con­tent providers, and advertisers.

3Qs: New GMO labeling law brings controversy, confusion

North­eastern pro­fessor and food policy expert Chris Bosso says there are honest argu­ments on each side of the debate over whether to label foods as having genet­i­cally mod­i­fied ingre­di­ents. But he notes the new bill, signed into law last week, is “a poor solu­tion to a com­plex problem.”